These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 8036000)

  • 1. Mutations that abolish the ability of Ha-Ras to associate with Raf-1.
    Shirouzu M; Koide H; Fujita-Yoshigaki J; Oshio H; Toyama Y; Yamasaki K; Fuhrman SA; Villafranca E; Kaziro Y; Yokoyama S
    Oncogene; 1994 Aug; 9(8):2153-7. PubMed ID: 8036000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different structural requirements within the switch II region of the Ras protein for interactions with specific downstream targets.
    Moodie SA; Paris M; Villafranca E; Kirshmeier P; Willumsen BM; Wolfman A
    Oncogene; 1995 Aug; 11(3):447-54. PubMed ID: 7630628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GTP-dependent association of Raf-1 with Ha-Ras: identification of Raf as a target downstream of Ras in mammalian cells.
    Koide H; Satoh T; Nakafuku M; Kaziro Y
    Proc Natl Acad Sci U S A; 1993 Sep; 90(18):8683-6. PubMed ID: 8378348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Normal and oncogenic p21ras proteins bind to the amino-terminal regulatory domain of c-Raf-1.
    Zhang XF; Settleman J; Kyriakis JM; Takeuchi-Suzuki E; Elledge SJ; Marshall MS; Bruder JT; Rapp UR; Avruch J
    Nature; 1993 Jul; 364(6435):308-13. PubMed ID: 8332187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of the sites of interaction between c-Raf-1 and Ras-GTP.
    Barnard D; Diaz B; Hettich L; Chuang E; Zhang XF; Avruch J; Marshall M
    Oncogene; 1995 Apr; 10(7):1283-90. PubMed ID: 7731678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel, activated RAS mutations alter protein-protein interactions.
    Dalley BK; Cannon JF
    Oncogene; 1996 Sep; 13(6):1209-20. PubMed ID: 8808695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regional polysterism in the GTP-bound form of the human c-Ha-Ras protein.
    Ito Y; Yamasaki K; Iwahara J; Terada T; Kamiya A; Shirouzu M; Muto Y; Kawai G; Yokoyama S; Laue ED; Wälchli M; Shibata T; Nishimura S; Miyazawa T
    Biochemistry; 1997 Jul; 36(30):9109-19. PubMed ID: 9230043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. R-Ras is regulated by activators and effectors distinct from those that control Ras function.
    Huff SY; Quilliam LA; Cox AD; Der CJ
    Oncogene; 1997 Jan; 14(2):133-43. PubMed ID: 9010215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Requirement for Ras in Raf activation is overcome by targeting Raf to the plasma membrane.
    Leevers SJ; Paterson HF; Marshall CJ
    Nature; 1994 Jun; 369(6479):411-4. PubMed ID: 8196769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential structural requirements for interaction of Ras protein with its distinct downstream effectors.
    Akasaka K; Tamada M; Wang F; Kariya K; Shima F; Kikuchi A; Yamamoto M; Shirouzu M; Yokoyama S; Kataoka T
    J Biol Chem; 1996 Mar; 271(10):5353-60. PubMed ID: 8621388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuclear magnetic resonance and molecular dynamics studies on the interactions of the Ras-binding domain of Raf-1 with wild-type and mutant Ras proteins.
    Terada T; Ito Y; Shirouzu M; Tateno M; Hashimoto K; Kigawa T; Ebisuzaki T; Takio K; Shibata T; Yokoyama S; Smith BO; Laue ED; Cooper JA
    J Mol Biol; 1999 Feb; 286(1):219-32. PubMed ID: 9931261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of Raf-1 in human pancreatic adenocarcinoma.
    Berger DH; Jardines LA; Chang H; Ruggeri B
    J Surg Res; 1997 Apr; 69(1):199-204. PubMed ID: 9202670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct interaction of Ras and the amino-terminal region of Raf-1 in vitro.
    Warne PH; Viciana PR; Downward J
    Nature; 1993 Jul; 364(6435):352-5. PubMed ID: 8332195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What makes Ras an efficient molecular switch: a computational, biophysical, and structural study of Ras-GDP interactions with mutants of Raf.
    Filchtinski D; Sharabi O; Rüppel A; Vetter IR; Herrmann C; Shifman JM
    J Mol Biol; 2010 Jun; 399(3):422-35. PubMed ID: 20361980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncogenic insertional mutations in the P-loop of Ras are overactive in MAP kinase signaling.
    Klockow B; Ahmadian MR; Block C; Wittinghofer A
    Oncogene; 2000 Nov; 19(47):5367-76. PubMed ID: 11103938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TC21 and Ras share indistinguishable transforming and differentiating activities.
    Graham SM; Oldham SM; Martin CB; Drugan JK; Zohn IE; Campbell S; Der CJ
    Oncogene; 1999 Mar; 18(12):2107-16. PubMed ID: 10321735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A constitutive effector region on the C-terminal side of switch I of the Ras protein.
    Fujita-Yoshigaki J; Shirouzu M; Ito Y; Hattori S; Furuyama S; Nishimura S; Yokoyama S
    J Biol Chem; 1995 Mar; 270(9):4661-7. PubMed ID: 7876237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ras-interacting domain of Ral GDP dissociation stimulator like (RGL) reverses v-Ras-induced transformation and Raf-1 activation in NIH3T3 cells.
    Okazaki M; Kishida S; Murai H; Hinoi T; Kikuchi A
    Cancer Res; 1996 May; 56(10):2387-92. PubMed ID: 8625316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coassociation of Rap1A and Ha-Ras with Raf-1 N-terminal region interferes with ras-dependent activation of Raf-1.
    Hu CD; Kariya Ki; Kotani G; Shirouzu M; Yokoyama S; Kataoka T
    J Biol Chem; 1997 May; 272(18):11702-5. PubMed ID: 9115221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ras- and Raf-mediated regulation of transforming growth factor beta 1 gene expression by ligands of tyrosine kinase receptors in PC12 cells.
    Cosgaya JM; Aranda A
    Oncogene; 1996 Jun; 12(12):2651-60. PubMed ID: 8700524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.